Research Areas
Biography and Research Information
OverviewAI-generated summary
Taylor McElory's research investigates the effects of chemotherapy regimens on cognitive function and the gut microbiome. Their work, as evidenced by their 2025 publication on cyclophosphamide, methotrexate, and 5-fluorouracil, examines the implications of these treatments on hippocampal-dependent cognition and the associated changes in gut microbial communities. McElory collaborates with researchers at the University of Arkansas for Medical Sciences, including Michael S. Robeson, Antiño R. Allen, Beth Cronin, and Christa Corley, on shared publications. This research contributes to understanding the complex interplay between cancer treatments, neurological health, and the microbiome.
Metrics
- h-index: 1
- Publications: 1
- Citations: 1
Selected Publications
-
Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome (2025)
Collaboration Network
Top Collaborators
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
- Implications of cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy on hippocampal-dependent cognition and gut microbiome
Similar Researchers
Based on overlapping research topics